Blog

Jan 29

Gender-Affirming Reproductive Health in Primary Care

This presentation offers an overview for clinicians who would like to learn more about providing patients with gender-affirming reproductive health care in primary care. Includes a variety of cases to review with learners. If you are interested in CME credit, you can request a workshop. For more information visit our CE webpage.

Jan 28

Insights: The Impacts of Abortion Bans on Maternal Health

Written by Silpa Srinivasulu, MPH After the Dobbs v Jackson Women’s Health decision overturned Roe v. Wade in June 2022, nearly half of US states banned or severely restricted access to abortion care. To date, 12 states ban abortion in nearly all circumstances and six restrict abortion at 12 weeks of pregnancy or less. While…

Jan 21

Possible Drug Interaction Between GLP-1 Agonist and Oral Contraceptives

Written by Sabina Kapkayeva Pharm.D. candidate and Regina Ginzburg, Pharm.D., CDCES, BC-ADM Glucagon-like peptide-1 (GLP-1 agonists) and glucose-dependent insulinotropic peptides (GIP) are increasingly being used in the management of diabetes and/or for weight loss. Several GLP-1 agonist medications available today are known to have interactions with oral hormonal contraceptives, but not through the usual pharmacokinetic…

Dec 24

Insights: Trying to Conceive After Early Pregnancy Loss

Written by C. Peony Khoo, MD Early pregnancy loss (EPL) – also called miscarriage or spontaneous abortion – is the spontaneous loss of a pregnancy before 13 weeks’ gestation. EPL is common, occurring in up to 15% of clinically recognized pregnancies, and nearly one in four people capable of pregnancy will experience EPL in their…